NCT05615701

Brief Summary

EOSedge is a precise, low dose imaging system that delivers full body, high-quality images covering the full set of musculoskeletal and orthopedic exams. The objective of the study is to evaluate the quality of the focused pelvis/hip X-ray images on EOSedge compared to those performed on DR (current practice) to perform a preoperative radiographic evaluation of hip implant, A sufficient image quality on focused X-ray images performed on EOSedge would allow (1) to avoid the passage on two different radiographic systems (saving time) (2) to reduce the patient's x-ray radiation dose

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 14, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

November 16, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2023

Completed
Last Updated

September 21, 2023

Status Verified

September 1, 2023

Enrollment Period

6 months

First QC Date

October 27, 2022

Last Update Submit

September 18, 2023

Conditions

Keywords

EOSRadiographyHipHip replacementImage quality

Outcome Measures

Primary Outcomes (1)

  • Score of Image quality

    Each criteria is quantitative and combined to obtain a final quantitative score : * Perfect reproduction = 2 / Moderate reproduction = 1 / Poor or uninterpretable reproduction = 0 * Artifacts ? = no or absence of periprosthetic material = 1; YES = 0 * X-ray image acceptable ? = Fully acceptable = 2; Acceptable only under limited clinical conditions = 1; Unacceptable (indicate why) = 0; OUTOCOME = FINAL SCORE 1. European C, Directorate-General for R, Innovation, Carmichael J, Moores B, Maccia C. Guide européen relatif aux critères de qualité des clichés de radiodiagnostic: Publications Office, 2000. 2. Kogon PL, Lumsden R. How do you critique your radiographs? The Journal of the Canadian Chiropractic Association. 1993; 37(4):230-232. 3. Cook JV, Kyriou JC, Pettet A, Fitzgerald MC, Shah K, Pablot SM. Key factors in the optimization of paediatric X-ray practice. The British journal of radiology. 2001; 74(887):1032-1040.

    Day 0

Secondary Outcomes (2)

  • Dosimetry

    Day 0

  • Dosimetry

    Day 0

Study Arms (1)

EOSedge imaging

OTHER

Single arm study : All subjects include in the study underwent micro-dose EOS x-ray and digital radiography for radiographic evaluation of hip implant

Diagnostic Test: EOSedge imaging

Interventions

EOSedge imagingDIAGNOSTIC_TEST

Hip X-ray evaluation in an EOSedge imaging for preoperative assessment for hip replacement or revision surgery

EOSedge imaging

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient 18 years of age or older
  • Came to the imaging department to perform a preoperative assessment for hip replacement or revision

You may not qualify if:

  • Patient under guardianship or curatorship
  • Patient participating in an interventional study
  • Patient unable to read and/or write

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Departement of Medical Imaging

Montpellier, Occitanie, 34295, France

Location

MeSH Terms

Conditions

Osteoarthritis, Hip

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Catherine c-cyteval@chu-montpellier.fr, MD, PhD

    Departement of Medical Imaging - Montpellier University hospital LAPEYRONIE Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2022

First Posted

November 14, 2022

Study Start

November 16, 2022

Primary Completion

May 5, 2023

Study Completion

May 5, 2023

Last Updated

September 21, 2023

Record last verified: 2023-09

Locations